Your session is about to expire
← Back to Search
Other
Fat Injection for Carpal Tunnel Syndrome
Phase < 1
Waitlist Available
Led By Melvin P Rosenwasser, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year post-treatment
Awards & highlights
Summary
This study applies the regenerative properties of autologous fat transfer to treat mild to moderate carpal tunnel syndrome in comparison to the current standard of care, corticosteroid treatment. The investigators hypothesize the fat transfer would prevent scar formation and aid in nerve excursion along the canal (while the neoangiogenic and regenerative growth factors could stimulate nerve regeneration) better than the standard of care treatment.
Eligible Conditions
- Carpal Tunnel Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1 year post-treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year post-treatment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Functional Outcome Score
Secondary study objectives
Score on the Brigham Women's Carpal Tunnel Questionnaire
Score on the Michigan Hand Questionnaire (MHQ)
Side effects data
From 2018 Phase 4 trial • 1670 Patients • NCT0226172732%
COPD Exacerbation - not hospitalised
16%
COPD Exacerbation - Hospitalised
7%
Upper Respiratory Tract Infection
100%
80%
60%
40%
20%
0%
Study treatment Arm
Low-dose Theophylline Arm
Placebo
Theophylline and Prednisone Arm
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Fat InjectionExperimental Treatment1 Intervention
Subjects with CTS will receive fat injection.
Group II: Steroid InjectionActive Control1 Intervention
Subjects with CTS will receive steroid injection.
Find a Location
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,471 Previous Clinical Trials
2,536,250 Total Patients Enrolled
Orthopaedic Scientific Research FoundationUNKNOWN
Melvin P Rosenwasser, MDPrincipal InvestigatorDepartment of Orthopaedic Surgery at Columbia University Medical Center
2 Previous Clinical Trials
700 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger